newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics Reports Second Quarter 2020 Financial and Operating Results

TTI-621 study has progressed to the 2.0 mg/kg dosing levelTTI-622 showing early evidence of monotherapy activity$130.8 million of cash and investments as of June 30, 2020 CAMBRIDGE, Mass., Aug. ...